Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Stomach Neoplasms × Imiquimod × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1 Breast 1

Conditions

Glioma 5 Glioblastoma 5 Melanoma 3 Uterine Cervical Dysplasia 2 Keratosis, Actinic 2 Ependymoma 2 Breast Neoplasms 2 Brain Neoplasms 2 Astrocytoma 2 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Stomach Neoplasms 1 Sialorrhea 1 Sarcoma 1 Precancerous Conditions 1 Non-Muscle Invasive Bladder Neoplasms 1 Neurofibromatosis 1 1 Neoplasm Metastasis 1 Medulloblastoma 1 Colorectal Neoplasms 1 Carcinoma, Basal Cell 1 Bone Neoplasms 1 Atypical Squamous Cells of the Cervix 1 Adenocarcinoma 1

Interventions

Cisplatin 24 pembrolizumab 23 Oxaliplatin 22 Fluorouracil 22 Irinotecan 21 Capecitabine 19 Leucovorin 17 Paclitaxel 16 Cyclophosphamide 14 Trastuzumab 11 Carboplatin 11 Nivolumab 10 Docetaxel 9 Bevacizumab 9 fludarabine 8 S 1 (combination) 8 Gemcitabine 8 aldesleukin 7 Ramucirumab 7 atezolizumab 6 130-nm albumin-bound paclitaxel 6 Taxes 5 Radiotherapy 5 Magnetic Resonance Spectroscopy 5 Biopsy 5 veliparib 4 tislelizumab 4 dehydroftorafur 4 Sunitinib 4 Specimen Handling 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02276300 2019-11-20

HER2

Technical University of Munich

Phase 1 Completed

BreastGastrointestinal

Breast Neoplasms, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡